Sign Up to like & get
recommendations!
1
Published in 2020 at "Cancer Medicine"
DOI: 10.1002/cam4.3298
Abstract: We explored the potential overall survival (OS) benefit of bleomycin, etoposide, doxorubicin (Adriamycin), cyclophosphamide, vincristine (Oncovin), procarbazine, and prednisone (BEACOPP) over doxorubicin (Adriamycin), bleomycin, vinblastine, and dacarbazine (ABVD) in a pooled analysis of four randomized…
read more here.
Keywords:
analysis four;
four randomized;
overall survival;
pooled analysis ... See more keywords